Acute Lymphoblastic Leukemia: Clinical Trials

11 trials for Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 11

Follow Acute Lymphoblastic Leukemia: new trials by email Literature Review of Acute Lymphoblastic Leukemia trials Research Report on Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
inotuzumab ozogamicin - Acute Lymphoblastic Leukemia
Phase 4CompletedPfizer442023-02-242025-12-03
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
inotuzumab ozogamicin-dose level 2, Inotuzumab ozogamicin-dose level 1 - Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma
Phase 4CompletedPfizer1022019-07-012023-11-22
Vaccinating Children After Chemotherapy
Prevnar®13, Pneumovax® 23, Pediacel® - Acute Lymphoblastic Leukemia
Phase 4CompletedCanadian Immunization Research Network1562015-11-162022-06-24
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
Cyclophosphamide, Doxorubicin, Vincristine - Acute Lymphoblastic Leukemia
Phase 4CompletedRuijin Hospital1002010-12-012014-05-20
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Prednisolone, Daunorubicin, Vincristine - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation402005-06-012014-10-28
Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Vincristine, Daunorubicin, Prednisone - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation1002003-01-012020-04-07
LAL-BR/2001: Study Treatment to Low Risk ALL
Prednisone, Vincristine, Daunorubicin - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation1502001-06-012016-01-20
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Vincristine, Daunorubicin, Prednisone - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation1002000-01-012010-01-05
Learning Impairments Among Survivors of Childhood Cancer
Methylphenidate - Acute Lymphoblastic Leukemia, Brain Tumors
Phase 4CompletedSt. Jude Children's Research Hospital4692000-01-012017-05-30
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Asparaginase, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation3741996-06-012009-05-19
Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
vincristine, dexamethasone - Acute Lymphoblastic Leukemia
Phase 4CompletedInternational BFM Study Group26001995-04-012006-12-14

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (11)  ·  Brain Neoplasms (1)  ·  Leukemia (1)  ·  Neoplasm, Residual (1)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (11)  ·  Hemic and Lymphatic Diseases (11)  ·  Immune System Diseases (11)  ·  Immunoproliferative Disorders (11)  ·  Leukemia, Lymphoid (11)  ·  Lymphatic Diseases (11)  ·  Lymphoproliferative Disorders (11)  ·  Neoplasms (11)  ·  Neoplasms by Histologic Type (11)  ·  Leukemia (10)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)

Interventions

Vincristine (7)  ·  Cytarabine (6)  ·  Asparaginase (5)  ·  Cyclophosphamide (5)  ·  Daunorubicin (5)  ·  Mercaptopurine (5)  ·  Methotrexate (5)  ·  Prednisone (5)  ·  Dexamethasone (4)  ·  Hydrocortisone (2)  ·  Inotuzumab Ozogamicin (2)  ·  Mitoxantrone (2)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  Doxorubicin (1)  ·  Etoposide (1)

Sponsors

PETHEMA Foundation (5)  ·  Pfizer (2)  ·  Canadian Immunization Research Network (1)  ·  International BFM Study Group (1)  ·  Ruijin Hospital (1)  ·  St. Jude Children's Research Hospital (1)

Countries

Spain (6)  ·  China (2)  ·  Hungary (2)  ·  United States (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Poland (1)  ·  Singapore (1)

Top investigators

Bastida Pilar, Dr (2)  ·  Edina Magyarosy, MD (1)  ·  Eduardo Dibar, MD (1)  ·  Giuseppe Masera, MD (1)  ·  Heather M Conklin (1)  ·  Helmut Gadner, MD (1)  ·  Ives Benoit, MD (1)  ·  Jan Stary, MD (1)  ·  Karina Top, MD, MS (1)  ·  Martin Schrappe, MD (1)  ·  Myriam Campbell, MD (1)  ·  Weili Zhao, MD,PhD (1)

Results publications

PMID 17223475, PMID 19564304, PMID 24752047, PMID 32067048, PMID 35622074, PMID 39882642

NIH funding

2018 (1), P30CA021765 (1), R01CA078957 (1), U01CA081445 (1)